ERIS LIFESCIENCES Acquisition (ERIS IN, Mkt Cap USD1.4b, CMP INR863, TP INR930, 8% Upside, Neutral) Acquisition: Click here to access detailed report Acquisition details Insulin portfolio/MABs to enhance coverage of …
@ 2023 – Blogoday. All Right Reserved.
